Semliki Forest Virus-Based Expression of Recombinant GPCRs

被引:0
作者
Lundstrom, Kenneth [1 ]
机构
[1] PanTherapeutics, Lutry, Switzerland
来源
MEMBRANE PROTEINS - PRODUCTION AND FUNCTIONAL CHARACTERIZATION | 2015年 / 556卷
关键词
PROTEIN-COUPLED RECEPTOR; HIGH-LEVEL EXPRESSION; SINDBIS VIRUS; CELL-LINES; PHARMACOLOGICAL CHARACTERIZATION; MAMMALIAN-CELLS; GENE-EXPRESSION; 5-HT3; RECEPTOR; IN-VITRO; VECTORS;
D O I
10.1016/bs.mie.2014.11.047
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Due to their importance as targets for drug development, rapid and consistent high-level production of G protein-coupled receptors (GPCRs) has become an essential part of drug discovery. Alphaviruses, particularly recombinant Semliki Forest virus (SFV) particles, have provided the means for expression of a number of GPCRs in a broad range of mammalian host cell lines for pharmacological characterization by determination of receptor binding activity and functional coupling to G proteins. The rapid high-titer virus particle production has made it possible to study a large number of GPCRs in parallel. Moreover, large-scale production in adherent and suspension cultures of mammalian cells has provided sufficient amounts of GPCRs for purification and subsequent structural studies. Furthermore, the high preference for neuronal delivery of SFV particles has allowed functional and localization studies of recombinant proteins in hippocampal slice cultures, in primary neurons, and in vivo.
引用
收藏
页码:331 / 350
页数:20
相关论文
共 50 条
  • [41] Cargo-Compatible Encapsulation in Virus-Based Nanoparticles
    Li, Lingling
    Xu, Chengchen
    Zhang, Wenjing
    Secundo, Francesco
    Li, Chunyan
    Zhang, Zhi-Ping
    Zhang, Xian-En
    Li, Feng
    NANO LETTERS, 2019, 19 (04) : 2700 - 2706
  • [42] PKR acts early in infection to suppress Semliki Forest virus production and strongly enhances the type I interferon response
    Barry, Gerald
    Breakwell, Lucy
    Fragkoudis, Rennos
    Attarzadeh-Yazdi, Ghassem
    Rodriguez-Andres, Julio
    Kohl, Alain
    Fazakerley, John K.
    JOURNAL OF GENERAL VIROLOGY, 2009, 90 : 1382 - 1391
  • [43] A Sendai Virus-Based Cytoplasmic RNA Vector as a Novel Platform for Long-Term Expression of MicroRNAs
    Sano, Masayuki
    Nakasu, Asako
    Ohtaka, Manami
    Nakanishi, Mahito
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 15 : 371 - 382
  • [44] Durability of a Vesicular Stomatitis Virus-Based Marburg Virus Vaccine in Nonhuman Primates
    Mire, Chad E.
    Geisbert, Joan B.
    Agans, Krystle N.
    Satterfield, Benjamin A.
    Versteeg, Krista M.
    Fritz, Elizabeth A.
    Feldmann, Heinz
    Hensley, Lisa E.
    Geisbert, Thomas W.
    PLOS ONE, 2014, 9 (04):
  • [45] Reverse Genetics of SARS-Related Coronavirus Using Vaccinia Virus-Based Recombination
    van den Worm, Sjoerd H. E.
    Eriksson, Klara Kristin
    Zevenhoven, Jessika C.
    Weber, Friedemann
    Zuest, Roland
    Kuri, Thomas
    Dijkman, Ronald
    Chang, Guohui
    Siddell, Stuart G.
    Snijder, Eric J.
    Thiel, Volker
    Davidson, Andrew D.
    PLOS ONE, 2012, 7 (03):
  • [46] Phenoloxidase Activity Acts as a Mosquito Innate Immune Response against Infection with Semliki Forest Virus
    Rodriguez-Andres, Julio
    Rani, Seema
    Varjak, Margus
    Chase-Topping, Margo E.
    Beck, Markus H.
    Ferguson, Mhairi C.
    Schnettler, Esther
    Fragkoudis, Rennos
    Barry, Gerald
    Merits, Andres
    Fazakerley, John K.
    Strand, Michael R.
    Kohl, Alain
    PLOS PATHOGENS, 2012, 8 (11)
  • [47] Expression of herpes simplex virus type 1 DNA polymerase by recombinant vaccinia virus
    Kronenwett, Ralf
    Weisshart, Klaus
    Knopf, Charles W.
    VIRUS GENES, 2009, 38 (02) : 232 - 242
  • [48] A novel system for the production of high levels of functional human therapeutic proteins in stable cells with a Semliki Forest virus noncytopathic vector
    Casales, Erkuden
    Aranda, Alejandro
    Quetglas, Jose I.
    Ruiz-Guillen, Marta
    Rodriguez-Madoz, Juan R.
    Prieto, Jesus
    Smerdou, Cristian
    NEW BIOTECHNOLOGY, 2010, 27 (02) : 138 - 148
  • [49] A Semliki Forest virus vector engineered to express IFNα induces efficient elimination of established tumors
    Quetglas, J. I.
    Fioravanti, J.
    Ardaiz, N.
    Medina-Echeverz, J.
    Baraibar, I.
    Prieto, J.
    Smerdou, C.
    Berraondo, P.
    GENE THERAPY, 2012, 19 (03) : 271 - 278
  • [50] VLDLR mediates Semliki Forest virus neuroinvasion through the blood-cerebrospinal fluid barrier
    Martikainen, Miika
    Lugano, Roberta
    Pietila, Ilkka
    Brosch, Sofie
    Cabrolier, Camille
    Sivaramakrishnan, Aishwarya
    Ramachandran, Mohanraj
    Yu, Di
    Dimberg, Anna
    Essand, Magnus
    NATURE COMMUNICATIONS, 2024, 15 (01)